🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 13 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/10/2015 | 51,72 | 55,94 | 51,72 | 55,80 | +5,91% | 8,17% | 625.491 |
| 01/10/2015 | 53,33 | 54,09 | 50,61 | 52,69 | -1,39% | 6,52% | 652.742 |
| 30/09/2015 | 52,88 | 55,33 | 50,85 | 53,43 | +4,32% | 8,47% | 852.636 |
| 29/09/2015 | 51,18 | 53,84 | 49,69 | 51,22 | -0,39% | 8,09% | 857.124 |
| 28/09/2015 | 56,89 | 57,52 | 49,73 | 51,42 | -10,15% | 13,70% | 1.183.816 |
| 25/09/2015 | 61,40 | 61,63 | 55,72 | 57,22 | -5,61% | 9,62% | 814.003 |
| 24/09/2015 | 60,82 | 61,14 | 57,70 | 60,62 | -1,03% | 5,64% | 539.730 |
| 23/09/2015 | 60,47 | 61,78 | 58,71 | 61,25 | +1,53% | 5,08% | 289.502 |
| 22/09/2015 | 60,01 | 61,00 | 58,96 | 60,33 | -1,22% | 3,41% | 562.653 |
| 21/09/2015 | 64,25 | 64,84 | 59,96 | 61,07 | -3,96% | 7,60% | 637.513 |
| 18/09/2015 | 62,38 | 63,85 | 62,38 | 63,59 | +0,26% | 2,35% | 660.276 |
| 17/09/2015 | 60,92 | 63,93 | 60,38 | 63,43 | +5,01% | 5,83% | 487.793 |
| 16/09/2015 | 60,84 | 61,52 | 59,26 | 60,41 | -0,40% | 3,70% | 391.773 |
| 15/09/2015 | 58,66 | 61,12 | 58,34 | 60,65 | +3,26% | 4,74% | 416.459 |
| 14/09/2015 | 59,57 | 59,60 | 58,02 | 58,73 | -0,84% | 2,66% | 323.806 |
| 11/09/2015 | 58,08 | 59,39 | 57,09 | 59,23 | +1,70% | 3,97% | 423.192 |
| 10/09/2015 | 57,56 | 58,85 | 57,22 | 58,24 | +0,84% | 2,84% | 370.453 |
| 09/09/2015 | 59,43 | 59,71 | 57,55 | 57,75 | -1,69% | 3,63% | 482.663 |
| 08/09/2015 | 57,19 | 58,95 | 56,33 | 58,75 | +4,81% | 4,57% | 341.599 |
| 04/09/2015 | 54,91 | 56,33 | 54,59 | 56,05 | +1,02% | 3,18% | 293.509 |
| 03/09/2015 | 58,15 | 58,63 | 55,00 | 55,48 | -3,77% | 6,25% | 381.835 |
| 02/09/2015 | 55,83 | 57,68 | 55,22 | 57,65 | +4,45% | 4,41% | 364.041 |
| 01/09/2015 | 56,01 | 57,01 | 54,76 | 55,20 | -3,76% | 4,02% | 664.444 |
| 31/08/2015 | 59,18 | 60,26 | 57,22 | 57,36 | -3,26% | 5,13% | 377.987 |
| 28/08/2015 | 58,33 | 59,66 | 58,08 | 59,29 | +0,84% | 2,72% | 522.738 |
| 27/08/2015 | 57,39 | 59,88 | 56,77 | 58,80 | +3,70% | 5,42% | 653.703 |
| 26/08/2015 | 55,09 | 56,77 | 53,28 | 56,70 | +5,61% | 6,34% | 570.508 |
| 25/08/2015 | 54,00 | 55,43 | 53,14 | 53,69 | +3,46% | 4,25% | 781.623 |
| 24/08/2015 | 48,97 | 53,27 | 44,69 | 51,89 | -1,68% | 17,53% | 1.200.487 |
| 21/08/2015 | 52,93 | 55,19 | 52,10 | 52,78 | -2,46% | 5,83% | 924.290 |